Business NewsEventsNewsPhysicians

VIVA THE VEINS! THE VEINS, A TWO-DAY COURSE IN VIVA 2018, OFFERS INTERDISCIPLINARY VASCULAR EDUCATION

For the past 16 years, world-renowned specialists from across the vascular intervention and medicine spectrum have converged in Las Vegas to make VIVA (Vascular InterVentional Advances) a growing educational event for the dedicated vascular specialist. This year, VIVA 2018 will be Nov. 5-8 at the Wynn Las Vegas.

The VEINS (Venous Endovascular INterventional Strategies) is a two-day interactive course Nov. 5-6, focusing on pulmonary embolism treatment, controversies in VTE management, management of superficial venous disease and late state venous disease. The VEINS will conclude two days before the American College of Phlebology opens its 32nd Annual Congress in Nashville.

The VEINS course directors, Raghu Kolluri, MD, and John Kaufman, MD, will head a multidisciplinary faculty of 44 vascular medical specialists as they addressing the challenges of preventing, diagnosing and managing venous disease. The VEINS will explore the complexities of caring for a diverse and growing patient population.

Attending will be interventional cardiologists, vascular medicine specialists, interventional radiologists, vascular surgeons, internists, fellows, nurses, nurse practitioners, physician assistants and technologists interested in exploring cutting-edge and future strategies for venous treatment, and those who are interested in a complete understanding of venous disease.

Sessions on Monday, Nov. 5, includes presentations two: Pharmaco RX and Nurses + Techs: Moderated sessions include Pharmacotherapy in PAD and New Medical Approaches in PVD; and in Nurses + Techs sessions include Chronic Limb Threatening Ischemia, Carotid Stenosis and Stroke, Venous Disease, New Tools, Tips and Tricks for Managing Complex Vascular Issues, and Vascular PharmacoRx—The Road Ahead.

On Tuesday, Nov. 6, moderated sessions on “Critical Limb Ischemia” include: CLI Basics in 2018; The ABCs of CLI Intervention; Controversies in CLI; Overcoming Challenges and Achieving Success; and Case in Point—Expert Management of the Hardest CLI Patients. Sessions under the heading of “Aortic Armageddon” include: Current Challenges and Unmet Needs; Ongoing Dilemmas in Tevar; and Managing Complications. The fellows and residents’ session that will wind up the day is How to Find the Right First Job and Set Yourself Up for Success.

Upon completion of The VEINS, the targeted learners should be able to:

  • Understand medical, endovascular and surgical therapies for chronic venous disease.
  • Appreciate the role of noninvasive technologies, including physiologic testing, duplex ultrasonography, and CT and MR venography, and invasive diagnostics, such as intravascular ultrasound, in the management of venous disease.
  • Appreciate the available therapeutic options and understand contemporary data in the management of superficial and deep vein disease.
  • Analyze the guidelines and available data and complications arising from the placement of IVC filters.
19 CLINICAL TRIAL
RESULTS TO BE PRESENTED AT VIVA!

The results of 19 clinical trials never presented to the public before will be featured at VIVA18. This group represents the most late-breaking clinical trial results ever presented at VIVA.

 

Results will be presented in four different sessions taking place on Tuesday and Wednesday, November 6 and 7. Below is the agenda for Wednesday, November 7.

 

Wednesday, November 7

 

9:19-10:19am

 

Lutonix® Below-the-Knee Global DCB IDE Study—Outcomes at 6 Months
Jihad Mustapha, MD
Innovative Resorbable Large Bore Closure Technology
Mike Watts, MD
2-Year Results From the SENTRY Bioconvertible IVC Filter Clinical Trial
Michael Dake, MD
PERFECT Registry: Pan-Pelvic Endovascular Intervention for Erectile Dysfunction
Tzung-Dau Wang, MD PhD
Full Cohort 12-Month Safety and Efficacy Results of the VMI-CFA Trial
Koen Deloose, MD

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Buffalo Jacobs School of Medicine and Biomedical Sciences and VIVA Physicians.

The University of Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians. This course is designated for a maximum of 15.0 AMA PRA Category 1 Credits.

Vascular medical specialists unable to attend VIVA can purchase and download the previous VIVA conferences, including all presentations, faculty information, videos of live cases, coding and billing sheets, and more.  These are not designed to be online courses, so you must physicially attend the conference in order to obtain CME credits.

All lectures are digitized and presented in streaming format for your computer and mobile device. To purchase previous conferences, see vivapvd.com/conference/PreviousConferences/Purchase.aspx

For more information about The VEINS 2018, including registration information, see vivaphysicians.org/agenda . VTN

 

 

Previous post

RA MEDICAL'S IPO DELIVERS $86 MILLION

Next post

FUJIFILM SONOSOFT SOLIDIFIES WORKFLOW WITH SYNCHRONICITY

Larry Storer

Larry Storer

Larry Storer has been editor of Vein Therapy News for 10 years. He has edited computer, shelter and medical publications at Publications & Communications LP for 30 years. He was also a corporate vice president and editorial director before retiring. Larry graduated from Baylor University with a BA in journalism and an MA in communications; and from Lamar University with a MED in school administration. He taught beginning and advanced reporting, beginning and advanced editing and editorial writing at Baylor University. Larry was a reporter, and city and news editor of the Beaumont Journal, and opinion editor at the Beaumont Enterprise and Beaumont Enterprise-Journal. He was also the founding managing editor of the Yuba City (California) Daily Independent-Herald.